Newsroom
Newsroom
Industry News
- September 26, 2023
Industry News
- August 29, 2023
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Industry News
- May 26, 2023
Industry News
- May 24, 2023
Brewer’s yeast engineered with synthetic biology to produce drugs or raw materials could transform pharmaceutical supply chains. ...
Industry News
- March 28, 2023
Our co-founder and CEO, Christina Smolke, was named to Forbes’ list of top ten women founders taking the synthetic biology world by storm. From her...
Industry News
- December 7, 2022
Drug Discovery and Development highlighted key drug discovery and development predictions for 2023. Antheia was highlighted for its take on the synbio industry's renewed focus...
Industry News
- September 26, 2023
Industry News
- August 29, 2023
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Blog Posts
- August 29, 2023
Press Releases
- August 21, 2023
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Blog Posts
- August 21, 2023
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first...
Blog Posts
- August 17, 2023
As the newly appointed Senior Vice President of Commercialization, Richard Sherwin is poised to move Antheia into its next phase by building a vibrant commercial...
Industry News
- September 26, 2023
Industry News
- August 29, 2023
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Industry News
- May 26, 2023
Industry News
- May 24, 2023
Brewer’s yeast engineered with synthetic biology to produce drugs or raw materials could transform pharmaceutical supply chains. ...
Industry News
- March 28, 2023
Our co-founder and CEO, Christina Smolke, was named to Forbes’ list of top ten women founders taking the synthetic biology world by storm. From her...
Industry News
- December 7, 2022
Drug Discovery and Development highlighted key drug discovery and development predictions for 2023. Antheia was highlighted for its take on the synbio industry's renewed focus...
Press Releases
- August 21, 2023
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Press Releases
- August 17, 2023
Press Releases
- April 6, 2023
Antheia, the pharmaceutical ingredient manufacturer transforming supply chains, today announced the appointment of John Nicols to Chair its Board of Directors. Nicols joins co-founders Dr....
Press Releases
- June 22, 2022
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank,...
Press Releases
- February 22, 2022
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer. ...
Press Releases
- November 18, 2021
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Zack McGahey as Chief Operating Officer......
Blog Posts
- August 29, 2023
Blog Posts
- August 21, 2023
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first...
Blog Posts
- August 17, 2023
As the newly appointed Senior Vice President of Commercialization, Richard Sherwin is poised to move Antheia into its next phase by building a vibrant commercial...
Blog Posts
- July 11, 2023
Blog Posts
- June 28, 2023